These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18840283)

  • 1. Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality data.
    Durot M; Le Fèvre F; de Berardinis V; Kreimeyer A; Vallenet D; Combe C; Smidtas S; Salanoubat M; Weissenbach J; Schachter V
    BMC Syst Biol; 2008 Oct; 2():85. PubMed ID: 18840283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baylyi ADP1 as a model for metabolic system biology.
    de Berardinis V; Durot M; Weissenbach J; Salanoubat M
    Curr Opin Microbiol; 2009 Oct; 12(5):568-76. PubMed ID: 19709925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE.
    Kim HU; Kim TY; Lee SY
    Mol Biosyst; 2010 Feb; 6(2):339-48. PubMed ID: 20094653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Mutation Rate and Increased Transformability of Transposon-Free Acinetobacter baylyi ADP1-ISx.
    Suárez GA; Renda BA; Dasgupta A; Barrick JE
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and modeling of transcriptional cross-regulation in Acinetobacter baylyi ADP1.
    Zhang D; Zhao Y; He Y; Wang Y; Zhao Y; Zheng Y; Wei X; Zhang L; Li Y; Jin T; Wu L; Wang H; Davison PA; Xu J; Huang WE
    ACS Synth Biol; 2012 Jul; 1(7):274-83. PubMed ID: 23651250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter baylyi ADP1: transforming the choice of model organism.
    Elliott KT; Neidle EL
    IUBMB Life; 2011 Dec; 63(12):1075-80. PubMed ID: 22034222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated genome annotation and metabolic model reconstruction in the SEED and Model SEED.
    Devoid S; Overbeek R; DeJongh M; Vonstein V; Best AA; Henry C
    Methods Mol Biol; 2013; 985():17-45. PubMed ID: 23417797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1.
    de Berardinis V; Vallenet D; Castelli V; Besnard M; Pinet A; Cruaud C; Samair S; Lechaplais C; Gyapay G; Richez C; Durot M; Kreimeyer A; Le Fèvre F; Schächter V; Pezo V; Döring V; Scarpelli C; Médigue C; Cohen GN; Marlière P; Salanoubat M; Weissenbach J
    Mol Syst Biol; 2008; 4():174. PubMed ID: 18319726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved triacylglycerol production in Acinetobacter baylyi ADP1 by metabolic engineering.
    Santala S; Efimova E; Kivinen V; Larjo A; Aho T; Karp M; Santala V
    Microb Cell Fact; 2011 May; 10():36. PubMed ID: 21592360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating high-throughput and computational data elucidates bacterial networks.
    Covert MW; Knight EM; Reed JL; Herrgard MJ; Palsson BO
    Nature; 2004 May; 429(6987):92-6. PubMed ID: 15129285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter sp. ADP1: an ideal model organism for genetic analysis and genome engineering.
    Metzgar D; Bacher JM; Pezo V; Reader J; Döring V; Schimmel P; Marlière P; de Crécy-Lagard V
    Nucleic Acids Res; 2004; 32(19):5780-90. PubMed ID: 15514111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring alkane degradation by single BioBrick integration to an optimal cellular framework.
    Santala S; Karp M; Santala V
    ACS Synth Biol; 2012 Feb; 1(2):60-4. PubMed ID: 23651046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomically and biochemically accurate metabolic reconstruction of Methanosarcina barkeri Fusaro, iMG746.
    Gonnerman MC; Benedict MN; Feist AM; Metcalf WW; Price ND
    Biotechnol J; 2013 Sep; 8(9):1070-9. PubMed ID: 23420771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinetobacter baylyi ADP1-naturally competent for synthetic biology.
    Santala S; Santala V
    Essays Biochem; 2021 Jul; 65(2):309-318. PubMed ID: 33769448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MaGe: a microbial genome annotation system supported by synteny results.
    Vallenet D; Labarre L; Rouy Z; Barbe V; Bocs S; Cruveiller S; Lajus A; Pascal G; Scarpelli C; Médigue C
    Nucleic Acids Res; 2006; 34(1):53-65. PubMed ID: 16407324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewiring the wax ester production pathway of Acinetobacter baylyi ADP1.
    Santala S; Efimova E; Koskinen P; Karp MT; Santala V
    ACS Synth Biol; 2014 Mar; 3(3):145-51. PubMed ID: 24898054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome instability mediates the loss of key traits by Acinetobacter baylyi ADP1 during laboratory evolution.
    Renda BA; Dasgupta A; Leon D; Barrick JE
    J Bacteriol; 2015 Mar; 197(5):872-81. PubMed ID: 25512307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic model refinement using phenotypic microarray data.
    Gawand P; Yang L; Cluett WR; Mahadevan R
    Methods Mol Biol; 2013; 985():47-59. PubMed ID: 23417798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstruction of a genome-scale metabolic network of Rhodococcus erythropolis for desulfurization studies.
    Aggarwal S; Karimi IA; Lee DY
    Mol Biosyst; 2011 Nov; 7(11):3122-31. PubMed ID: 21912787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting gene essentiality using genome-scale in silico models.
    Joyce AR; Palsson BØ
    Methods Mol Biol; 2008; 416():433-57. PubMed ID: 18392986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.